Fidelity Group of Funds > Fidelity Covington Trust
Fidelity Disruptive Medicine ETF
$47.34M
Avg Monthly Net Assets
$51.55M
Total Assets
$1.63M
Total Liabilities
$49.93M
Net Assets
Fidelity Disruptive Medicine ETF is an Exchange-Traded Fund in Fidelity Covington Trust
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has one share class
and monthly net assets of $47.34M.
On July 26th, 2024 it reported 62 holdings, the largest
being BOSTON SCIENTIFIC CORP (6.6%), UNITEDHEALTH GROUP INC (4.3%) and DANAHER CORP (3.9%).
Data provided by Fincoded.
Share Classes
Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
---|---|---|---|---|
Fidelity Disruptive Medicine ETF | C000240928 | XNMS | FMED |
Holdings
From latest NPORT-P, filed July 26th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
---|---|---|---|---|---|---|
10X GENOMICS INC | Long | Equity-common | US | $521K | 23K | 1.04 |
AGILON HEALTH INC | Long | Equity-common | US | $520K | 82K | 1.04 |
ALIGN TECHNOLOGY INC | Long | Equity-common | US | $475K | 2K | 0.95 |
ALNYLAM PHARMACEUTICALS INC | Long | Equity-common | US | $2M | 11K | 3.23 |
ALX ONCOLOGY HOLDINGS INC | Long | Equity-common | US | $179K | 17K | 0.36 |
ARCELLX INC | Long | Equity-common | US | $206K | 4K | 0.41 |
ARGENX SE SPONSORED ADR | Long | Equity-common | NL | $1M | 3K | 2.24 |
ARROWHEAD PHARMACEUTICALS INC | Long | Equity-common | US | $315K | 14K | 0.63 |
ASCENDIS PHARMA AS SPON ADR (ASCENDIS PHARMA A/S) | Long | Equity-common | DK | $522K | 4K | 1.05 |
BIO TECHNE CORP | Long | Equity-common | US | $972K | 13K | 1.95 |
BOSTON SCIENTIFIC CORP | Long | Equity-common | US | $3M | 44K | 6.63 |
BRUKER CORP | Long | Equity-common | US | $548K | 8K | 1.10 |
CENTENE CORP (CENTENE CORP DEL) | Long | Equity-common | US | $2M | 24K | 3.48 |
CYTOKINETICS INC | Long | Equity-common | US | $569K | 12K | 1.14 |
DANAHER CORP | Long | Equity-common | US | $2M | 8K | 3.86 |
DEXCOM INC | Long | Equity-common | US | $868K | 7K | 1.74 |
DOXIMITY INC | Long | Equity-common | US | $332K | 12K | 0.67 |
EDGEWISE THERAPEUTICS INC | Long | Equity-common | US | $256K | 15K | 0.51 |
EDWARDS LIFESCIENCES CORP | Long | Equity-common | US | $1M | 13K | 2.26 |
ELI LILLY and CO | Long | Equity-common | US | $1M | 2K | 2.49 |
EVOLENT HEALTH INC A | Long | Equity-common | US | $456K | 22K | 0.91 |
EXACT SCIENCES CORP | Long | Equity-common | US | $979K | 22K | 1.96 |
Fidelity Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $461K | 461K | 0.92 |
Fidelity Securities Lending Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $2M | 2M | 3.20 |
GLAUKOS CORP | Long | Equity-common | US | $969K | 9K | 1.94 |
GUARDANT HEALTH INC | Long | Equity-common | US | $334K | 12K | 0.67 |
HUMANA INC | Long | Equity-common | US | $708K | 2K | 1.42 |
INSPIRE MEDICAL SYSTEMS INC | Long | Equity-common | US | $925K | 6K | 1.85 |
INSULET CORP | Long | Equity-common | US | $2M | 9K | 3.24 |
INTELLIA THERAPEUTICS INC | Long | Equity-common | US | $179K | 8K | 0.36 |
INTUITIVE SURGICAL INC | Long | Equity-common | US | $2M | 5K | 3.66 |
IRHYTHM TECHNOLOGIES INC | Long | Equity-common | US | $247K | 3K | 0.50 |
JANUX THERAPEUTICS INC | Long | Equity-common | US | $751K | 14K | 1.50 |
KEROS THERAPEUTICS (KEROS THERAPEUTICS INC) | Long | Equity-common | US | $247K | 5K | 0.50 |
LEGEND BIOTECH CORP SPON ADR | Long | Equity-common | KY | $1M | 27K | 2.19 |
LIFESTANCE HEALTH GROUP INC | Long | Equity-common | US | $1M | 184K | 2.06 |
LONZA GROUP AG | Long | Equity-common | CH | $573K | 1K | 1.15 |
MASIMO CORP | Long | Equity-common | US | $858K | 7K | 1.72 |
MERCK and CO INC NEW | Long | Equity-common | US | $1M | 10K | 2.41 |
NATERA INC | Long | Equity-common | US | $461K | 4K | 0.92 |
PENUMBRA INC | Long | Equity-common | US | $1M | 6K | 2.35 |
PHREESIA INC | Long | Equity-common | US | $464K | 25K | 0.93 |
PRIVIA HEALTH GROUP INC | Long | Equity-common | US | $590K | 34K | 1.18 |
REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $1M | 1K | 2.64 |
REPLIGEN (REPLIGEN CORP) | Long | Equity-common | US | $839K | 6K | 1.68 |
RESMED INC | Long | Equity-common | US | $711K | 3K | 1.42 |
ROYALTY PHARMA PLC | Long | Equity-common | GB | $1M | 38K | 2.07 |
SAREPTA THERAPEUTICS INC | Long | Equity-common | US | $640K | 5K | 1.28 |
SARTORIUS STEDIM BIOTECH | Long | Equity-common | FR | $594K | 3K | 1.19 |
STRUCTURE THERAPEUTICS INC ADR | Long | Equity-common | KY | $215K | 6K | 0.43 |
STRYKER CORP | Long | Equity-common | US | $1M | 4K | 2.66 |
TANDEM DIABETES CARE INC | Long | Equity-common | US | $573K | 11K | 1.15 |
THERMO FISHER SCIENTIFIC INC | Long | Equity-common | US | $1M | 2K | 2.17 |
TYRA BIOSCIENCES INC | Long | Equity-common | US | $258K | 16K | 0.52 |
UNITEDHEALTH GROUP INC | Long | Equity-common | US | $2M | 4K | 4.25 |
VAXCYTE INC | Long | Equity-common | US | $652K | 9K | 1.31 |
VEEVA SYS INC CL A | Long | Equity-common | US | $903K | 5K | 1.81 |
VERTEX PHARMACEUTICALS INC | Long | Equity-common | US | $520K | 1K | 1.04 |
WEST PHARMACEUTICAL SVCS INC | Long | Equity-common | US | $537K | 2K | 1.08 |
XENON PHARMACEUTICALS INC | Long | Equity-common | CA | $589K | 15K | 1.18 |
ZAI LAB LTD UNSPNRD ADR | Long | Equity-common | KY | $326K | 18K | 0.65 |
ZENTALIS PHARMACEUTICALS LLC (ZENTALIS PHARMACEUTICALS INC) | Long | Equity-common | US | $167K | 14K | 0.34 |
Address
Fidelity Covington Trust
245 Summer Street
Boston
Massachusetts
02210
United States of America
Directors
Oscar Munoz
Robert A Lawrence
Thomas A Kennedy
Bettina Doulton
Vicki L Fuller
Vijay Advani
Thomas P Bostick
Karen B. Peetz
Patricia L Kampling
Donald F Donahue
Michael E Wiley
Susan Tomasky
David M Thomas
Transfer Agents
STATE STREET BANK AND TRUST COMPANY
Pricing Services
INTERCONTINENTAL EXCHANGE INC
REFINITIV US HOLDINGS INC
Custodians
SKANDINAVISKA ENSKILDA BANKEN
BNP PARIBAS GREECE
CITIBANK NA
HSBC NEW ZEALAND
BANCO NACIONAL DE MEXICO SA
HSBC AUSTRALIA
Citibank N.A
CITIBANK SINGAPORE
CITIBANK NA
EUROCLEAR
CESKOSLOVENSKA OBCHODNI BANKA
DEUTSCHE BANK PHILIPPINES
BANK HAPOALIM BM
FIRST ABU DHABI BANK
THE HONGKONG + SHANGHAI BANKIN
SKANDINAVISKA ENSKILDA BANKEN
INTESA SANPAOLO SPA
Standard Chartered Bank
BNP PARIBAS BELGIUM
BNP PARIBAS FRANCE
UNICREDIT BANK AUSTRIA AG
STANBIC IBTC BANK PLC
STATE STREET BANK AND TRUST COMPANY
DUETSCHE BANK AG INDONESIA
Banco de Chile
AS SEB Pank
HONGKONG AND SHANGHAI BANKING CORP LTD
STANDARD CHARTERED BANK KENYA LIMITED
SSB GMBH GERMANY - CBF
CITITRUST COLOMBIA SA SOCIEDAD
STATE STREET TRUST COMPANY CANADA
CITIBANK MAGHREB MOROCCO
SEB NORWAY
HSBC BANK EGYPT SAE
FIRSTRAND BANK LIMITED
CITIBANK N.A.
HSBC - JAPAN
SEB FINLAND
Citibank del Peru SA
Citibank Europe Plc
CITIBANK EUROPE PLC
STANDARD CHARTERED BANK
UNICREDIT BANK HUNGARY ZRT
UBS AG
STATE STREET SERVICES (UK) LIMITED
First Abu Dhabi Bank
STANDARD CHARTERED BANK
STANDARD CHARTERED BANK
HSBC BANK MIDDLE EAST LIMITED
BANK HANDLOWY W WARSZAWIE SA
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
STANDARD CHARTERED
HSBC BANK (CHINA) COMPANY LIMITED
BNP PARIBAS NETHERLANDS
Shareholder Servicing Agents
STATE STREET BANK AND TRUST COMPANY
Admins
Fidelity Service Company
Brokers
JEFFERIES FINANCIAL GROUP INC
UBS GROUP AG
BANK OF AMERICA CORPORATION
JEFFERIES GROUP LLC
MORGAN STANLEY
GOLDMAN SACHS GROUP INC (THE)
JPMORGAN CHASE and CO
MACQUARIE GROUP LTD
CITIGROUP INC
BNP PARIBAS